adenovirus
adv
nonenvelop
icosahedr
doublestrand
dna
virus
infect
number
vertebr
host
includ
human
nonhuman
primat
genu
mastadenoviru
within
adenovirida
famili
includ
human
adenovir
speci
ag
hadva
hadvg
simian
adenovir
speci
sadva
human
infect
adenovirus
caus
conjunct
gastroenter
hepat
myocard
acut
respiratori
ill
rang
common
cold
syndrom
fatal
outbreak
pneumonia
howev
exist
anim
model
adenoviru
infect
date
primarili
confin
rodent
nonhuman
primat
nhp
model
establish
studi
adenovirus
infect
human
andor
nhp
previous
identifi
novel
adenoviru
titi
monkey
adenoviru
tmadv
associ
fatal
outbreak
pneumonia
hepat
close
coloni
captiv
new
world
titi
monkey
callicebu
cupreu
evid
potenti
crossspeci
transmiss
human
research
famili
member
concurr
acut
respiratori
symptom
origin
natur
host
reservoir
tmadv
remain
unknown
although
neutral
antibodi
tmadv
found
titi
monkey
demonstr
clinic
sign
titi
monkey
expos
anim
demonstr
clinic
sign
rhesu
macaqu
macaca
mulatta
human
studi
group
also
reveal
widespread
presenc
close
relat
adenovirus
human
nonhuman
primat
largescal
serolog
survey
detect
antibodi
monkey
adenovirus
human
live
endem
region
addit
human
adenoviru
speci
e
g
contain
one
member
isol
human
remain
member
isol
monkey
ape
collect
data
rais
concern
regard
potenti
adenovirus
sourc
emerg
zoonot
diseas
human
investig
pathogen
novel
adenoviru
tmadv
sought
develop
vivo
anim
model
infect
diseas
tmadv
tmadv
origin
discov
close
coloni
captiv
titi
monkey
callicebu
cupreu
california
nation
primat
research
center
cnprc
recogn
vivo
test
monkey
speci
contraind
due
signific
devast
coloni
caus
viru
sinc
tmadv
abl
success
propag
marmoset
lymphocyt
cell
line
vitro
tabl
instead
elect
pursu
vivo
test
tmadv
infect
common
marmoset
callithrix
jacchu
common
marmoset
new
world
primat
small
easili
handl
highli
suscept
infecti
agent
thu
suitabl
nonhuman
primat
model
infecti
diseas
marmoset
success
use
character
number
emerg
viral
diseas
includ
filoviru
arenavirusinduc
hemorrhag
fever
enceph
sever
acut
respiratori
syndrom
sar
sinc
titi
monkey
famili
pithecida
subfamili
callicebinia
marmoset
monkey
famili
cebida
subfamili
callitrichina
classifi
separ
famili
use
marmoset
vivo
test
tmadv
infect
also
afford
opportun
directli
test
capac
tmadv
extens
adenovirus
gener
cross
speci
barrier
caus
product
infect
relat
yet
taxonom
distinct
secondari
host
previous
abl
success
propag
tmadv
human
lung
adenocarcinoma
cell
line
viral
adapt
assess
robust
cytopath
effect
cpe
occur
passag
wildtyp
earli
passag
strain
grew
poorli
avail
human
monkey
cell
fulli
adapt
passag
abl
effici
infect
type
cell
fig
understand
molecular
basi
behind
adapt
unbias
nextgener
deep
sequenc
use
resequ
tmadv
genom
correspond
origin
isol
deriv
lung
swab
correspond
titi
monkey
die
tmadv
pneumonia
passag
cell
fig
approxim
million
nucleotid
read
gener
per
sampl
read
correspond
origin
isol
passag
passag
respect
map
tmadv
genom
consensu
genom
calcul
map
read
scan
identifi
snp
singl
nucleotid
polymorph
differ
sangersequenc
tmadv
genom
genbank
access
number
total
snp
detect
sangersequenc
tmadv
genom
genom
assembl
deep
sequenc
fig
two
snp
ident
three
tmadv
genom
assembl
thu
like
correspond
pcr
andor
sequenc
error
origin
sangersequenc
viral
genom
sole
remain
snp
mutat
posit
result
put
amino
acid
chang
prolin
arginin
posit
tmadv
protein
pcr
clone
sequenc
short
gene
segment
encompass
posit
differ
viral
passag
confirm
correl
presenc
mutat
passag
tmadv
adapt
cell
begin
passag
fig
tabl
sinc
adenovir
protein
known
interact
degrad
cellular
dna
repair
protein
mrn
complex
multipl
amino
acid
sequenc
align
protein
perform
tmadv
repres
human
simian
adenovirus
determin
whether
identifi
mutat
might
involv
fig
amino
acid
chang
found
locat
put
region
protein
next
attempt
propag
tmadv
varieti
human
monkey
cell
line
tabl
product
infect
assess
magnitud
cpe
observ
cell
line
test
notabl
moder
growth
tmadv
seen
use
marmoset
lymphoblastoid
cell
new
world
monkey
cell
line
test
human
epitheli
colorect
cell
lung
cell
hfdl
also
support
tmadv
replic
examin
tmadv
infect
inocul
marmoset
intranas
ml
viru
suffici
viral
stock
avail
inocul
dose
chosen
similar
physiolog
dose
use
experiment
nasal
inocul
nonhuman
primat
tbri
acut
respiratori
virus
rsv
respiratori
syncyti
viru
three
marmoset
inocul
cultureadapt
tmadv
passag
one
marmoset
inocul
cell
cultur
media
control
fig
anim
appear
normal
approxim
day
infect
clinic
sign
present
inocul
monkey
clinic
score
fig
tabl
anim
exhibit
reduc
activ
decreas
stool
product
becam
anorex
develop
lowgrad
fever
marmoset
demonstr
sever
clinic
sign
guard
physic
condit
nasal
congest
sneez
day
day
experiment
infect
anim
recov
quickli
marmoset
fulli
recov
time
euthanasia
day
assess
effect
reinfect
tmadv
marmoset
reinocul
day
along
control
marmoset
observ
addit
day
prior
euthanasia
day
clinic
sign
infect
observ
marmoset
experiment
tmadv
anim
marmoset
experiment
control
anim
reinocul
clinic
score
nasal
swab
collect
experiment
marmoset
posit
tmadv
realtim
qrtpcr
day
postinocul
neg
day
time
euthanasia
fig
reinocul
nasal
swab
marmoset
posit
tmadv
day
reinocul
neg
day
time
euthanasia
calcul
viral
titer
rang
genom
copi
per
ml
qrtpcr
fig
evid
viremia
qrtpcr
nest
pcr
serum
sampl
marmoset
studi
data
shown
viru
neutral
assay
use
screen
experiment
infect
marmoset
develop
neutral
antibodi
ab
tmadv
fig
interestingli
wherea
marmoset
control
neg
preinocul
ab
titer
marmoset
preexist
antibodi
titer
antibodi
titer
tmadvinfect
marmoset
rose
day
postinocul
respect
wherea
antibodi
titer
marmoset
rose
slightli
day
antibodi
titer
remain
constant
upon
reinocul
marmoset
day
entir
followup
observ
period
signific
gross
patholog
lesion
observ
salient
histolog
find
specif
tmadvinocul
anim
tabl
mild
bronchiti
fig
focal
area
atyp
nodular
hyperplasia
liver
fig
observ
marmoset
tabl
inocul
anim
found
mild
enter
fig
andor
coliti
typic
basophil
intranuclear
inclus
consist
activ
adenoviru
infect
observ
tissu
tmadvinfect
marmoset
pauciti
histolog
find
observ
marmoset
experiment
infect
tmadv
sharp
contrast
strike
lesion
observ
moribund
titi
monkey
tmadvassoci
pneumonia
hepat
tabl
direct
immunofluoresc
assay
broad
detect
adenovirus
use
screen
tmadv
necropsi
tissu
experiment
infect
marmoset
current
studi
natur
infect
titi
monkey
previous
report
pneumonia
outbreak
area
bright
applegreen
fluoresc
predominantli
cytoplasm
observ
lung
tissu
titi
monkey
fatal
tmadv
pneumonia
fig
lung
intestin
tissu
experiment
tmadvinfect
marmoset
fig
confirm
neg
find
necropsi
marmoset
tissu
test
presenc
tmadv
realtim
qpcr
nest
pcr
tmadv
detect
necropsi
tissu
marmoset
two
pcr
assay
present
evid
support
infect
common
marmoset
tmadv
novel
adenoviru
previous
associ
acut
respiratori
ill
human
rapidli
fatal
hepat
pneumonia
titi
monkey
although
unabl
reisol
viru
blood
tissu
tmadvinfect
marmoset
nasal
cultur
posit
tmadv
realtim
qrtpcr
day
postinocul
tmadv
inocul
produc
clinic
appar
diseas
antibodi
respons
inocul
anim
thu
river
modif
koch
postul
recogn
addit
serolog
evid
antibodi
product
respons
viral
infect
fulfil
experiment
infect
nasal
inocul
physiolog
dose
result
acut
selfresolv
flulik
ill
start
around
day
postinocul
character
lowgrad
fever
reduc
activ
decreas
stool
product
anorexia
repeat
episod
sneez
observ
anim
accompani
increas
virusspecif
neutral
antibodi
titer
serum
inocul
anim
confirm
acut
product
yet
selflimit
infect
tmadv
marmoset
sole
anim
preexist
neutral
antibodi
tmadv
surpris
find
given
anticip
infect
tmadv
serolog
crossreact
new
world
monkey
adenoviru
preval
among
marmoset
popul
investig
possibl
ongo
gener
lack
signific
histolog
lesion
consist
activ
adenoviru
infect
inocul
anim
tabl
may
function
delay
appear
clinic
sign
necropsi
taken
togeth
result
demonstr
tmadv
infecti
caus
diseas
marmoset
clearli
document
abil
adenovirus
cross
speci
barrier
close
relat
host
vivo
infect
marmoset
physiolog
dose
tmadv
unabl
replic
rapidli
fatal
pneumonia
hepat
syndrom
seen
titi
monkey
infect
viru
pneumonia
outbreak
cnprc
tabl
necropsi
tissu
includ
lung
intestin
liver
neg
tmadv
albeit
complet
resolut
clinic
sign
although
mild
bronchiti
seen
one
tmadvinfect
marmoset
consist
acut
respiratori
infect
enter
andor
coliti
seen
inocul
marmoset
like
manifest
mild
marmoset
wast
syndrom
extrem
common
even
healthi
marmoset
popul
especi
given
absenc
intranuclear
inclus
bodi
neg
immunofluoresc
result
fig
differ
clinic
outcom
tmadv
infect
may
also
relat
anatom
differ
titi
monkey
common
marmoset
titi
monkey
enlarg
larynx
presenc
laryng
air
sac
describ
may
predispos
anim
aspir
pneumonia
secondari
laryng
swell
viral
infect
possibl
evid
sever
invas
infect
would
observ
increas
infecti
dose
number
experiment
infect
anim
serial
sacrific
experi
howev
natur
acquir
infect
adenovirus
typic
mild
fatal
outcom
rare
immunocompet
individu
notabl
clinic
sign
onethird
titi
monkey
document
infect
tmadv
previous
report
pneumonia
outbreak
antibodi
test
also
mild
absent
similar
inocul
marmoset
present
studi
infect
tmadv
human
research
cnprc
household
member
associ
selflimit
flulik
respiratori
ill
observ
peak
level
neutral
antibodi
respons
tmadv
infect
marmoset
current
studi
well
rhesu
monkey
titi
monkey
human
mildabs
clinic
sign
symptom
cnprc
outbreak
significantli
decreas
rel
titi
monkey
fulmin
pneumonia
level
neutral
antibodi
titer
may
thu
correl
diseas
sever
seen
respiratori
diseas
sar
associ
may
relat
phenomenon
immun
hyperact
cytokin
storm
critic
ill
individu
necropsi
tissu
test
neg
tmadv
pcr
immunofluoresc
tmadv
also
absent
blood
throughout
cours
infect
absenc
signific
viremia
tmadvinfect
marmoset
surpris
given
tmadv
viremia
rare
found
even
titi
monkey
fatal
pneumonia
hepat
tabl
result
indic
respiratori
tract
blood
may
primari
site
infect
replic
tmadv
inde
current
studi
abl
detect
tmadv
marmoset
week
postinocul
nasal
swab
blood
anoth
potenti
explan
differ
tmadv
infect
marmoset
human
acut
selfrespiratori
ill
titi
monkey
fulmin
pneumonia
may
attenu
virul
serial
passag
inocul
strain
lone
amino
acid
chang
adenovir
protein
fig
tabl
previous
note
adapt
tmadv
cell
cultur
requir
passag
robust
growth
old
world
monkey
rhesu
african
green
monkey
human
cell
present
studi
uncov
molecular
basi
adapt
hypothes
singl
code
alter
passag
may
promot
growth
adapt
tmadv
cultur
yet
may
attenu
infect
andor
virul
viru
vivo
clinic
signific
alter
unclear
origin
prolin
residu
posit
found
simian
bovin
porcin
tree
shrew
human
adenovirus
data
shown
chang
arginin
posit
note
sequenc
adenoviru
date
experi
investig
role
amino
acid
chang
infect
underway
differ
manifest
tmadvassoci
diseas
naturallyinfect
titi
monkey
experimentallyinfect
marmoset
also
surpris
given
member
two
differ
famili
nonhuman
primat
mani
viral
infect
monkey
herpesviru
b
infect
human
macaqu
spectrum
sever
diseas
vari
significantli
differ
albeit
relat
host
studi
product
infect
marmoset
tmadv
document
clinic
sign
ill
begin
day
specif
neutral
antibodi
respons
detect
viru
nasal
swab
week
postinocul
result
along
addit
data
recent
literatur
firmli
establish
infect
adenovirus
inde
cross
taxonom
barrier
within
differ
nonhuman
primat
human
host
addit
research
need
develop
common
marmoset
nonhuman
primat
model
adenoviru
diseas
especi
viral
strain
tmadv
potenti
caus
fulmin
ill
crossspeci
infect
studi
carri
strict
accord
recommend
guid
care
use
laboratori
anim
nation
institut
health
anim
biosafeti
level
condit
personnel
use
practic
approv
institut
biohazard
committe
texa
biomed
research
institut
tbri
protocol
marmoset
studi
pathogen
novel
adenoviru
tmadv
marmoset
anim
model
approv
institut
anim
care
use
committe
institut
biohazard
committe
tbri
tbri
accredit
associ
assess
accredit
laboratori
anim
care
aaalac
intern
oper
accord
nih
us
depart
agricultur
guidelin
anim
welfar
act
marmoset
kept
healthi
wellnourish
strict
feed
protocol
close
monitor
health
statu
prior
start
studi
entir
studi
period
one
week
inocul
anim
transfer
biosafeti
facil
tbri
hous
individu
cage
specif
develop
marmoset
work
marmoset
sedat
human
euthan
administr
sodium
pentobarbit
solut
licens
veterinarian
tbri
human
cell
line
hfdl
monkey
cell
line
pmk
vero
use
studi
previous
establish
routin
maintain
viral
rickettsi
diseas
laboratori
vrdl
branch
california
depart
public
health
use
viral
diagnost
studi
viral
supernat
cell
cultur
passag
gener
infecti
stock
subject
freezethaw
cycl
clarifi
centrifug
g
cell
achiev
confluenc
cell
cultur
media
chang
mainten
media
fb
inocul
passag
viral
supernat
viral
replic
monitor
day
visual
inspect
light
microscopi
cytopath
effect
cpe
earli
passag
tmadv
suitabl
gener
infecti
viral
stock
marmoset
inocul
poor
growth
insuffici
titer
monkey
human
cell
line
thu
vivo
work
experiment
marmoset
infect
use
wildtyp
earli
passag
tmadv
desir
practic
robust
growth
observ
passag
cell
appear
tmadv
result
amino
acid
chang
fig
reflect
tmadv
adapt
viral
stock
titer
prepar
passag
tmadv
initi
isol
pmk
cell
serial
passag
cell
fig
infecti
viral
stock
quantit
endpoint
dilut
assay
lung
swab
sampl
univers
transport
media
viral
supernat
pass
filter
millipor
temecula
ca
total
nucleic
acid
extract
perform
use
commerci
avail
kit
accord
manufactur
instruct
qiagen
valencia
ca
deep
sequenc
librari
prepar
use
variat
truseq
protocol
illumina
describ
previous
raw
sequenc
read
strip
adapt
primer
sequenc
align
refer
tmadv
genom
access
number
use
blastn
word
size
evalu
use
geneiou
softwar
read
trim
exclud
low
qualiti
base
region
map
tmadv
genom
consensu
sequenc
compar
refer
tmadv
genom
requir
ambigu
discrep
nucleotid
posit
three
healthi
adult
femal
marmoset
year
age
rang
weight
g
obtain
southwest
nation
primat
research
center
tbri
random
screen
anim
coloni
antibodi
test
previous
perform
virus
gbva
gb
viru
mlcv
marmoset
ebvlik
lymphocryptoviru
detect
individu
screen
perform
select
anim
particular
screen
tmadv
perform
priori
evid
viru
natur
infect
captiv
common
marmoset
one
addit
femal
marmoset
year
age
weigh
g
use
control
day
three
anim
transfer
facil
intranas
inocul
ml
viru
dilut
salin
remain
control
anim
receiv
equival
volum
dilut
cell
cultur
medium
predetermin
time
interv
anim
sedat
blood
nasal
swab
sampl
collect
viral
analysi
anim
began
exhibit
clinic
sign
day
postinocul
close
observ
evid
clinic
deterior
howev
anim
recov
quickli
day
two
experiment
infect
marmoset
randomli
select
euthan
remain
experiment
infect
marmoset
control
marmoset
reinocul
tmadv
control
media
respect
observ
addit
day
prior
euthanasia
day
purpos
reinocul
assess
whether
repeat
challeng
tmadv
would
result
sever
infect
whether
prior
infect
tmadv
confer
degre
protect
subsequ
exposur
viru
sampl
asept
remov
tissu
fix
neutral
buffer
formalin
embed
paraffin
histolog
paraffinembed
tissu
cut
section
deparaffin
stain
hematoxylin
eosin
h
e
prior
visual
light
microscopi
addit
sampl
freshli
frozen
liquid
nitrogen
kept
store
freezer
analyz
histolog
section
evalu
independ
two
boardcertifi
veterinari
pathologist
degre
tissu
inflamm
subject
grade
mild
moder
sever
nasal
swab
serum
tissu
experiment
infect
control
marmoset
screen
tmadv
use
qpcr
assay
adenovir
gene
standard
curv
analysi
previous
describ
neg
result
screen
use
sensit
nest
pcr
assay
hexon
gene
pcr
amplicon
confirm
tmadv
sanger
sequenc
primer
use
pcr
assay
list
tabl
frozen
tissu
cut
section
fix
aceton
minut
room
temperatur
stain
murin
monoclon
antibodi
adenoviru
hexon
diagnost
hybrid
athen
oh
conjug
fitc
minut
antibodi
previous
shown
broadli
detect
varieti
mammalian
adenovirus
stain
visual
use
epifluoresc
microscop
genbank
access
number
adenovir
sequenc
fig
follow
tmadv
titi
monkey
adenoviru
deep
sequenc
read
correspond
wildtyp
passag
passag
tmadv
submit
ncbi
sequenc
read
archiv
access
number
pend
